Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 20212021년 2월 룩셈부르크 SARS-CoV-2 B.1.351 변종으로 4건의 재감염 사례Rapid Communication Published on 2021-05-062022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, 치료기술, [키워드] affecting B.1.1.7 B.1.351 B.1.351 variant B1.351 Border Cluster COVID 19 COVID-19 Europe France HCW HCWs healthcare worker Healthcare workers hospital Luxembourg Masks occurred outbreak Patient PCR Re-infection recommendations SARS-CoV-2 SARS-CoV-2 B.1.351 variant surgical variant variants [DOI] 10.2807/1560-7917.ES.2021.26.18.2100423 PMC 바로가기 [Article Type] Rapid Communication
Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India남아프리카와 탄자니아에서 인도로 여행하는 여행자에게서 수입된 SARS-CoV-2 V501Y.V2 변종(B.1.351)이 감지되었습니다.Article Published on 2021-05-012022-09-11 Journal: Travel medicine and infectious disease [Category] SARS, 변종, 치료기술, [키워드] Abstract B.1.351 India N501Y SARS-CoV-2 South South Africa Tanzania variant variant of concern [DOI] 10.1016/j.tmaid.2021.102023 PMC 바로가기 [Article Type] Article
Linked Clusters of SARS-CoV-2 Variant B.1.351 — Maryland, January–February 2021SARS-CoV-2 변종 B.1.351의 연결된 클러스터 — 메릴랜드, 2021년 1월–2월Full Report Published on 2021-04-302022-09-10 Journal: Morbidity and Mortality Weekly Report [Category] MERS, SARS, 변종, [키워드] B.1.351 SARS-CoV-2 [DOI] 10.15585/mmwr.mm7017a5 PMC 바로가기 [Article Type] Full Report
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseReport Published on 2021-04-302022-10-28 Journal: Science (New York, N.y.) [Category] COVID-19, [키워드] abrogated analyzed antibody Antigen B cell response B.1.1.7 B.1.351 BNT162b2 Cell cross protective immunity dose effective ENhance first dose HCW healthcare worker Heterologous HLA Immunity individual Infection investigated leukocyte memory B mRNA vaccine neutralizing antibody Neutralizing antibody response Pfizer/BioNTech Polymorphisms receiving reduced SARS-COV-2 infection SARS-CoV-2 vaccine secreting single dose spike mutation Spread T cell T cell response vaccination vaccine dose variant variants variants of concern Wuhan-Hu-1 [DOI] 10.1126/science.abh1282 PMC 바로가기 [Article Type] Report
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced seraArticle Published on 2021-04-292022-10-31 Journal: Cell [Category] COVID-19, MERS, SARS, [키워드] abrogate Abstract ACE2 ACE2 binding acute respiratory syndrome Analysis angiotensin-converting enzyme-2 antibody AstraZeneca B.1.351 binding Brazil changes in convalescent coronavirus domain driven by E484K escape evidence of facilitate form Immune escape immunodominant K417N large cohort Lineage mAb monoclonal antibody Mutation N501Y neutralization neutralization titer Neutralizing NTD offer P.1 Pfizer receptor receptor ACE2 Receptor-binding domain reduced reveal SARS-CoV-2 SARS-CoV-2 isolate SARS-CoV-2 variant sequence sera serum serum sample serum samples South Africa Spike protein structure-function the SARS-CoV-2 vaccinated individual Vaccine vaccinee variant viral cell viral spike protein widespread [DOI] 10.1016/j.cell.2021.02.037 PMC 바로가기 [Article Type] Article
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesArticle Published on 2021-04-292022-10-06 Journal: Cell [Category] SARS, 진단, [키워드] Alter antibodies antibody B.1.1.7 B.1.351 bamlanivimab blockade Brazil camostat Casirivimab cell interaction convalescent COVID-19 patient COVID-19 COVID-19 pandemic effort Entry inhibitor escape health system host cell Host cell entry human cell implication individuals inhibited inhibitor less Mutation neutralization neutralizing antibody neutralizing antibody responses P.1 P.1 variant pandemic plasma Protein pseudoparticles recombinant SARS-CoV-2 SARS-CoV-2 variant sera soluble ACE2 South Africa Spike protein Spread susceptible Treatment variant variants variants of concern viral spike VoC [DOI] 10.1016/j.cell.2021.03.036 PMC 바로가기 [Article Type] Article
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera초기 유행성 혈청에 의한 우려의 SARS-CoV-2 변종에 대한 중화의 상관 관계Pathogenesis and Immunity Published on 2021-04-282022-09-10 Journal: Journal of Virology [Category] MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] antibodies B.1.1.7 B.1.351 B.1.351 variant binding characterized clinical feature Cohort concern convalescent COVID-19 convalescent patient COVID-19 pandemic Critical cross-neutralization effective Evidence exacerbate homologous immune responses Immunity immunological Increasing Infection investigated mechanism Mutation N-terminal domain nAb response NAb responses NAb titers natural immunity natural infection neutralization Neutralizing antibodies neutralizing antibody NTD overcome pandemic primary mechanism promote RBD Receptor binding domain reduced reduction in response SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants significantly spike gene stimulated subjects susceptibility T cell T cell responses T cells These data Vaccine-induced immunity Vaccines variant variants Virological [DOI] 10.1128/JVI.00404-21 PMC 바로가기 [Article Type] Pathogenesis and Immunity
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021우려되는 SARS-CoV-2 변종 B.1.1.7, B.1.351 또는 P.1의 특성: 7개 EU/EEA 국가의 데이터, 2020년 38월 ~ 2021년 10월Rapid Communication Published on 2021-04-222022-09-10 Journal: Eurosurveillance [Category] MERS, SARS, 변종, [키워드] 95% CI 95% confidence interval adjusted odds ratio Admission B.1.1.7 B.1.351 COVID-19 COVID-19 case COVID-19 cases Europe European gene target hospitalisation intensive care P.1 reported SARS-CoV-2 SARS-CoV-2 variant Seven significantly higher Surveillance variant variants of concern [DOI] 10.2807/1560-7917.ES.2021.26.16.2100348 PMC 바로가기 [Article Type] Rapid Communication
Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 20212021년 3월 독일, 5개의 SARS-CoV-2 RAT(Rapid Antigen Tests)에서 우려되는 B.1.1.7 및 B.1.351의 새로운 SARS-CoV-2 변이체 감지Rapid Communication Published on 2021-04-222022-09-10 Journal: Eurosurveillance [Category] MERS, SARS, 변종, 치료기술, [키워드] Abbott analysed B.1.1.7 B.1.351 cell culture supernatant clinical sample comparable conditions detect detection dilutions DMEM FIVE Germany investigated Laboratory molecular nal von minden new SARS-CoV-2 performance rapid antigen test Rapid antigen test(s) Rapid antigen tests RapiGEN RAT RATs Roche Saliva SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Siemens Surveillance Variant(s) of Concern variants of concern VoC while [DOI] 10.2807/1560-7917.ES.2021.26.16.2100413 PMC 바로가기 [Article Type] Rapid Communication
Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-CirculationArticle Published on 2021-04-222022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] Analysis Area B.1.1.7 B.1.351 biological properties co-circulation community transmission convalescent dominance Effectiveness examined GISAID database Heterologous Hypothesis introduced mAbs Mayotte monoclonal antibody pre-existing immunity proportion raise reported SARS-CoV-2 SARS-CoV-2 sequence SARS-CoV-2 variant sera South Africa Strains Temporal Transmissibility transmitted vaccination Vaccine Vaccines variant variants variants of concern VoC [DOI] 10.3390/life11050375 PMC 바로가기 [Article Type] Article